Research Progress on PANoptosis in Cerebral Ischemia-Reperfusion Injury
10.3870/j.issn.1672-0741.25.12.030
- VernacularTitle:泛凋亡在脑缺血再灌注损伤中的研究进展
- Author:
Kexin SHI
1
;
Ruiqing LI
2
;
Mengling HUANG
3
;
Jingjing LI
3
;
Yiran PENG
3
;
Xinran LI
3
;
Jiani GU
3
Author Information
1. School of Rehabilitation Sciences,Henan University of Chinese Medicine, Zhengzhou 450046, China; Rehabilitation Center, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China
2. Rehabilitation Center, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China
3. School of Rehabilitation Sciences,Henan University of Chinese Medicine, Zhengzhou 450046, China
- Publication Type:Journal Article
- Keywords:
PANoptosis;
PANoptosome;
cerebral ischemia-reperfusion injury
- From:
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
2026;55(5):765-774
- CountryChina
- Language:Chinese
-
Abstract:
Cerebral ischemia-reperfusion injury (CIRI) occurs when cerebral blood flow is restored following an ischemia episode. Although oxygen and nutrients are depleted during ischemia, the subsequent rapid reperfusion can paradoxically cause irreversible neuronal damage. CIRI involves multiple programmed cell death (PCD) pathways, including apoptosis, pyroptosis, and necroptosis. The recently proposed concept of PANoptosis highlights the close integration and molecular crosstalk among these three PCD modalities in inflammatory injury settings, offering a novel perspective for elucidating cell death mechanisms in CIRI. This review summarizes the definition of PANoptosis, the molecular composition of PANoptosomes, and the potential roles of different PANoptosome subtypes in CIRI, aiming to open new avenues for therapeutic intervention and drug development.